2026. OUTCOMES OF OXALIPLATIN- BASED ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: A RETROSPECTIVE STUDY AT HANOI MEDICAL UNIVERSITY HOSPITAL. Vietnam Journal of Community Medicine. 67, 10 (Oct. 2026). DOI:https://doi.org/10.52163/yhc.v67i10.6925.